EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SPP1 and MMP1 as key therapeutic targets of Jingfang Granule in idiopathic pulmonary fibrosis: integrated bioinformatics and machine learning analysis

Yifan Ren, Jingzhe Gao, Kunshuang Shen, Shan Jiang, Yaoyu Xie, Yuanyuan Wang, Xiaoran Sun, Yaoai Wang, Ning Zhang, Siju Lou, Jiaxin Ding, Bingxu Mu und 3 weitere

Frontiers in Pharmacology · 10.06.2026 · 17

DOI: 10.3389/fphar.2026.1739181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 10.06.2026. Verfasst von Yifan Ren und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, National Chinmedomics Research Center, National TC…. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease with limited therapeutic options. This study aims to identify potential efficacy biomarkers of Jingfang Granule (JFG) and investigate the therapeutic mechanism of its key active components against critical targets in IPF.

Methods

IPF-related targets were identified through bioinformatics analysis of a public IPF dataset. Co-expressed gene modules were identified using Weighted Gene Co-expression Network Analysis (WGCNA). The JFG-PF interaction network was constructed employing protein-protein interaction (PPI) methods and functional enrichment analysis, which included Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Variation Analysis (GSVA). Additionally, five types of machine learning techniques were utilized to obtain diagnostic markers, which were further analyzed in immune infiltration assessments to evaluate their associations with immune cells and potential therapeutic effects. Molecular docking and molecular dynamics simulations were conducted to validate these analytical results. Finally, immunohistochemistry and immunofluorescence were used for verification.

Results

A total of 3, 360 upregulated and 240 downregulated differentially expressed genes (DEGs) were identified in IPF sample. Integration of WGCNA findings with 1, 077 targets of JFG pinpointed 57 key genes lingking with IPF and JFG. Machine learning algorithms further refined this list, identifying four diagnostic markers:SPP1, MMP1, AKR1B10, and HTR2A. Immune infiltration analysis revealed that these biomarkers are significantly correlated with alterations in multiple immune cell populations within the IPF microenvironment. Molecular docking experiments strong binding affinities between the active compounds of JFG and these protein biomarkers. Subsequent in vitro validation results demonstrated that JFG significantly regulates the expression of SPP1 and MMP1 in lung fibroblasts, thereby attenuating fibrotic responses through the suppression of pro-fibrotic pathways.

Conclusion

The study identified four key genes as potential diagnostic markers for IPF and therapeutic targets for JFG. The finding preliminarily elucidate ther mechanisms of JFG in mitigating pulmonary fibrosis vis regulation of fibrotic pathways and the immune microenvironment, thereby providing an integrativeevidence chain for the development of novel-fibrotic therapeutic.

Schlagwörter

Stichwörter der Autor:innen

bioinformaticsidiopathic pulmonary fibrosismachine learningmolecular dockingmolecular dynamics simulation

Autor:innen und Institutionen

  • State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, National Chinmedomics Research Center, National TCM Key Laboratory of Serum Pharmacochemistry, Metabolomics Laboratory,…
  • State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co., Ltd., Linyi, China.

Zitieren

APA

Ren, Y., Gao, J., Shen, K., Jiang, S., Xie, Y., Wang, Y., Sun, X., Wang, Y., Zhang, N., Lou, S., Ding, J., Mu, B., Yan, G., Zhang, G., & Wang, X. (2026). SPP1 and MMP1 as key therapeutic targets of Jingfang Granule in idiopathic pulmonary fibrosis: integrated bioinformatics and machine learning analysis. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1739181

Vancouver

Ren Y, Gao J, Shen K, Jiang S, Xie Y, Wang Y, et al. SPP1 and MMP1 as key therapeutic targets of Jingfang Granule in idiopathic pulmonary fibrosis: integrated bioinformatics and machine learning analysis. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1739181

BibTeX
@article{Ren2026,
  author = {Ren, Yifan and Gao, Jingzhe and Shen, Kunshuang and Jiang, Shan and Xie, Yaoyu and Wang, Yuanyuan and Sun, Xiaoran and Wang, Yaoai and Zhang, Ning and Lou, Siju and Ding, Jiaxin and Mu, Bingxu and Yan, Guangli and Zhang, Guimin and Wang, Xijun},
  title = {SPP1 and MMP1 as key therapeutic targets of Jingfang Granule in idiopathic pulmonary fibrosis: integrated bioinformatics and machine learning analysis},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1739181}
}
Kostenlos starten →